Genufood Energy Enzymes Corp. (GFOO) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGenufood Energy Enzymes Corp. (GFOO) trades at $0.0001. Genufood Energy Enzymes Corp. is a shell company formerly involved in manufacturing and distributing enzyme products. Currently, the company does not have significant operations. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for GFOO: GFOO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Genufood Energy Enzymes Corp. (GFOO) Financial Services Profile
Genufood Energy Enzymes Corp., operating within the Financial Services sector as a shell company, lacks significant current operations after previously engaging in the manufacturing and distribution of enzyme products. The company's minimal market capitalization and high beta reflect its speculative nature and limited activity in the market.
What Is the Investment Thesis for GFOO?
Investing in Genufood Energy Enzymes Corp. (GFOO) presents a highly speculative opportunity. The company's current lack of significant operations and minimal market capitalization of $0.00B indicate substantial risk. The high beta of 5.09 suggests extreme volatility relative to the market. Potential value drivers hinge on the possibility of a reverse merger, acquisition, or strategic shift into a new business. However, without concrete plans or active operations, the investment thesis relies heavily on speculation. Investors should carefully consider the risks associated with shell companies and the lack of financial performance data.
Based on FMP financials and quantitative analysis
GFOO Key Highlights
Market capitalization of $0.00B indicates the company's small size and limited investor confidence.
- A P/E ratio of -0.13 reflects negative earnings and the company's lack of profitability.
- Beta of 5.09 suggests high volatility compared to the overall market.
- Dividend yield of None indicates that the company does not currently distribute profits to shareholders.
- The company's status as a shell company implies a high degree of uncertainty and risk.
Who Are GFOO's Competitors?
GFOO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ABVN ABV Consulting, Inc. | $1.02 | 0.00% | $103M | — |
| ACBD Annabidiol Corp. | $0.84 | 0.00% | $33.8M | — |
| BOREF Borealis Exploration Limited | $1.25 | -37.50% | $6.20M | — |
| CIIT Tianci International, Inc. | $2.39 | +3.67% | 32 5-pillar | |
| COLA Columbus Acquisition Corp | $2.86 | -60.82% | $12.9M | 44 5-pillar |
| ASPC A SPAC III Acquisition Corp. | $10.82 | +0.28% | $25.3M | 48 5-pillar |
| RIBB Ribbon Acquisition Corp | $7.11 | +10.06% | $35.7M | 43 5-pillar |
| AFJK Aimei Health Technology Co., Ltd | $12.12 | -1.86% | $38.3M | 43 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GFOO's Key Strengths?
Existing corporate structure
- Publicly listed status
- Potential for reverse merger
- Low market capitalization
What Are GFOO's Weaknesses?
Lack of active operations
- Minimal assets
- Negative earnings
What Are the Key Risks for GFOO?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Failure to find a suitable merger or acquisition target.
- Inability to raise capital to fund new ventures.
- Limited liquidity and trading volume.
- High volatility and speculative nature of the stock.
- Delisting from the OTC market.
What Are GFOO's Competitive Advantages?
- As a shell company, GFOO's primary advantage is its existing corporate structure and public listing.
- This can provide a faster and less expensive route to market for private companies seeking to go public.
- However, GFOO lacks a traditional economic moat due to its lack of active operations.
What Does GFOO Do?
Genufood Energy Enzymes Corp. was incorporated in 2010 and is based in Arcadia, California. The company's historical business involved the manufacturing, exporting, and distributing of enzyme products intended as supplements for both human and animal consumption. However, as of 2026, Genufood Energy Enzymes Corp. does not have significant ongoing operations. This transition from an active enzyme product business to a shell company represents a significant shift in the company's trajectory. The company's current state suggests a potential restructuring, acquisition target, or strategic pivot, although no specific plans have been publicly disclosed. The lack of current operations and minimal market capitalization reflect the speculative nature of the company's stock. The company's future direction remains uncertain, contingent on potential new ventures or strategic realignments.
What Products and Services Does GFOO Offer?
- Currently, Genufood Energy Enzymes Corp. does not have significant operations.
- Previously, the company manufactured enzyme products.
- The company exported enzyme products.
- They distributed enzyme products.
- The enzyme products were intended as supplements for human consumption.
- The enzyme products were also intended as supplements for animal consumption.
How Does GFOO Make Money?
- Historically, the company generated revenue through the sale of enzyme products.
- The company's business model involved manufacturing, exporting, and distributing these products.
- Currently, the company does not have an active business model.
What Industry Does GFOO Operate In?
Genufood Energy Enzymes Corp. operates within the shell company industry, a segment of the financial services sector characterized by companies with no active business operations or significant assets. These companies are often formed for the purpose of facilitating mergers, acquisitions, or reverse takeovers. The shell company industry is highly speculative, with potential for high returns but also significant risks. The competitive landscape is diverse, ranging from newly formed entities to established companies seeking to restructure or enter new markets. Genufood Energy Enzymes Corp.'s position as a shell company reflects its current lack of operational activity and dependence on future strategic developments.
Who Are GFOO's Key Customers?
- Historically, the company's customers included individuals seeking enzyme supplements.
- The company also served customers in the animal feed industry.
- Currently, the company does not have active customers.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Insider Activity
11 transactions · 6 purchases, 0 sales, 5 other transactions · 4 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Financial Health
Genufood Energy Enzymes Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Company Profile
Genufood Energy Enzymes Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Arcadia, US. The company is led by CEO David Tang. GFOO has traded publicly since 2013.
GFOO Financials
GFOO Latest News
No recent news available for GFOO.
GFOO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GFOO.
Price Targets
Wall Street price target analysis for GFOO.
GFOO MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GFOO; grades run from A+ (80-100) to F (below 30).
Leadership: David Tang
Unknown
David Tang is the managing member of Genufood Energy Enzymes Corp. His role involves overseeing the limited operations of the company, which currently functions as a shell corporation. The company employs only one individual, indicating a very lean operational structure.
Track Record: Given the company's current state as a shell corporation without significant operations, it is difficult to assess David Tang's track record in terms of driving revenue growth or achieving strategic milestones. His primary responsibility appears to be maintaining the company's corporate structure and exploring potential future opportunities.
GFOO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available, and may not be current in their reporting obligations. Investing in OTC Other stocks carries a higher degree of risk due to the potential for fraud, manipulation, and lack of transparency. These securities are often considered highly speculative.
- OTC Tier: OTC Other
- Limited or no financial disclosure
- High potential for fraud or manipulation
- Lack of liquidity
- Speculative nature of the company
- Potential for delisting or suspension of trading
- Verify the company's registration and legal status
- Review any available financial statements
- Assess the company's management team and their experience
- Research the company's history and any past legal issues
- Understand the risks associated with investing in OTC Other stocks
- Monitor trading volume and bid-ask spreads
- Consult with a financial advisor
- Verify the company's registration with the SEC or other regulatory bodies.
- Check for any history of regulatory violations or legal issues.
- Assess the experience and qualifications of the company's management team.
- Look for any independent audits or certifications.
- Monitor news and press releases for any red flags.
What Investors Ask About Genufood Energy Enzymes Corp. (GFOO) — Financials
What are the main risks for GFOO?
The main risks for Genufood Energy Enzymes Corp. stem from its status as a shell company with no active business operations.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on publicly available sources and may be limited due to the company's status as a shell corporation.
- The analysis is subject to change based on new information or events.